Literature DB >> 30885311

Outcome following olecranon osteotomy versus paratricipital approach for complex intra-articular (AO 13-C) fracture of distal humerus: a prospective comparative study.

Rahul Singh1, Naman Kanodia2, Harveer Singh3.   

Abstract

BACKGROUND: The paratricipital approach is a relatively new approach in a complex intra-articular fracture of distal humerus (AO13-C). The aim of this study was to ascertain this approach compared with the olecranon osteotomy approach. Also, we aimed to investigate whether advancing age and surgical delay yield a poor outcome.
MATERIALS AND METHODS: Between 2011 and 2015, 51 adult patients with closed AO 13-C-type fractures were included in the study and divided into 2 groups, that is, paratricipital approach (PT) group and olecranon osteotomy (OO) group. Patients were treated by 2 senior trauma surgeons. They were prospectively analyzed for outcome and complications. Mayo elbow performance score (MEPS) was used to evaluate the outcome.
RESULTS: Of the total 51 patients (mean age, 41.6 years), 27 patients were in the PT group and 24 in the OO group. There was no difference in arc of motion (P = .513) and MEPS (P = .127) as well as complication rate (χ2 statistic = 0.36, P = .54). However, specifically in the type C3 fracture, the PT group had a poor outcome for arc of motion (P = .002) and MEPS (P = .019) compared with the OO group. Also, age and surgical delay had a weak, negative correlation with arc of motion and MEPS. The association between age and surgical delay against arc of motion was statistically significant (P = .005 and .01, respectively).
CONCLUSIONS: The PT approach and the OO approach can be used alternatively for AO 13-C1 and -C2 fractures with similar outcomes. However, in type C3, the PT approach yields a poor outcome in comparison with the OO approach.
Copyright © 2019 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complex distal humeral fracture; olecranon osteotomy; paratricipital; surgical approach

Mesh:

Year:  2019        PMID: 30885311     DOI: 10.1016/j.jse.2019.01.002

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  6 in total

1.  Are Outcomes Comparable for Repair of AO/OTA Type 13C1 and Type 13C2 Distal Humeral Fractures Using the Paratricipital Approach?

Authors:  Soonchul Lee; Eugene Baek; Minwook Kim; Junhan Kim; Hyunil Lee; Do Kyung Kim; Yoon Jang; Soo-Hong Han
Journal:  Clin Orthop Surg       Date:  2022-04-26

2.  Reliability, validity and critical appraisal of the cross-cultural adapted German version of the Mayo Elbow Performance Score (MEPS-G).

Authors:  A Papen; T Schöttker-Königer; A Schäfer; F Morrison; B Hollinger; K J Burkhart; R Nietschke; A Zimmerer; N Maffulli; F Migliorini; Marco M Schneider
Journal:  J Orthop Surg Res       Date:  2022-06-25       Impact factor: 2.677

3.  Outcomes of AO/OTA C-type fractures of the distal humerus after open reduction and internal fixation with locking plate constructs in patients at least 65 years old.

Authors:  Kaarlo V Kervinen; Mikko T Salmela; Tuomas A Lähdeoja
Journal:  BMC Musculoskelet Disord       Date:  2022-06-01       Impact factor: 2.562

4.  Analysis of Factors Affecting Return to Work After Surgical Treatment in Patients with AO Type C Distal Humerus Fractures.

Authors:  Mert Kumbaraci; Can Doruk Basa; Ali Turgut
Journal:  Indian J Orthop       Date:  2020-09-19       Impact factor: 1.251

5.  Complications of olecranon osteotomy in the treatment of distal humerus fracture.

Authors:  Kimberley E Spierings; Bram J Schoolmeesters; Job N Doornberg; Denise Eygendaal; Michel Pj van den Bekerom
Journal:  Clin Shoulder Elb       Date:  2022-04-04

6.  Comparison of olecranon osteotomy and paratricipital approach in distal humerus intra-articular fracture: A systematic review and meta-analysis.

Authors:  Ho-Seung Jeong; Jae Young Yang; Seung Jun Jeon; Hyun-Chul Shon; Jong-Keon Oh; Eic Ju Lim
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.